Literature DB >> 22013071

Characterization of the Src/Abl hybrid kinase SmTK6 of Schistosoma mansoni.

Svenja Beckmann1, Steffen Hahnel, Katia Cailliau, Mathieu Vanderstraete, Edith Browaeys, Colette Dissous, Christoph G Grevelding.   

Abstract

Cellular protein-tyrosine kinases play key roles in signal transduction processes in eukaryotes. SmTK4 was the first Syk kinase identified in a parasite and found to be tissue-specifically transcribed in the gonads of adult Schistosoma mansoni. Functional analyses confirmed its role in oogenesis and spermatogenesis. As an SmTK4 upstream binding partner, the cellular protein-tyrosine kinase SmTK6 was isolated from a yeast two-hybrid library. Phylogenetic analyses performed in this study confirmed the first suggestions of a hybrid character of SmTK6. Biochemical studies made in Xenopus oocytes using inhibitors against Src (herbimycin A) and Abl (imatinib) kinases exhibited a biochemical inhibition profile of SmTK6, which was intermediate of Src and Abl kinases. As SmTK6 upstream interaction partners, we identified among others the known Src kinase SmTK3 and the Venus kinase receptor SmVKR1 of S. mansoni by yeast two-hybrid analyses, all of which co-localized in the gonads. Co-immunoprecipitation experiments confirmed interactions between SmTK6 and SmTK3 or SmVKR1. In Xenopus oocytes, it was finally shown that SmVKR1 but also SmTK3 were able to activate SmTK6 enzymatic activity indicating its functions in a receptor tyrosine kinase signal transduction cascade. These results not only demonstrate an intermediate but Src-biased profile of the unusual kinase SmTK6. They also strongly substantiate previous indications for a kinase complex, consisting of a receptor tyrosine kinase, Syk and Src kinases, which has been hypothesized to be involved in proliferation and differentiation processes in the gonads of schistosomes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22013071      PMCID: PMC3234968          DOI: 10.1074/jbc.M110.210336

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  Schistosome male-female interaction: induction of germ-cell differentiation.

Authors:  W Kunz
Journal:  Trends Parasitol       Date:  2001-05

Review 2.  Schistosomiasis.

Authors:  Allen G P Ross; Paul B Bartley; Adrian C Sleigh; G Richard Olds; Yuesheng Li; Gail M Williams; Donald P McManus
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

3.  Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland.

Authors:  J A Schroeder; M C Thompson; M M Gardner; S J Gendler
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

4.  A novel Syk-family tyrosine kinase from Schistosoma mansoni which is preferentially transcribed in reproductive organs.

Authors:  Jürgen Knobloch; Ralf Winnen; Marcus Quack; Werner Kunz; Christoph G Grevelding
Journal:  Gene       Date:  2002-07-10       Impact factor: 3.688

5.  Schistosomiasis.

Authors:  L Chitsulo; P Loverde; D Engels
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

Review 6.  Protein tyrosine kinase structure and function.

Authors:  S R Hubbard; J H Till
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

7.  An unusual receptor tyrosine kinase of Schistosoma mansoni contains a Venus Flytrap module.

Authors:  Jérôme Vicogne; Jean Philippe Pin; Vinca Lardans; Monique Capron; Christophe Noël; Colette Dissous
Journal:  Mol Biochem Parasitol       Date:  2003-01       Impact factor: 1.759

Review 8.  Tyrosine kinase and cooperative TGFbeta signaling in the reproductive organs of Schistosoma mansoni.

Authors:  Jürgen Knobloch; Svenja Beckmann; Cora Burmeister; Thomas Quack; Christoph G Grevelding
Journal:  Exp Parasitol       Date:  2007-04-22       Impact factor: 2.011

Review 9.  Imatinib: a selective tyrosine kinase inhibitor.

Authors:  P W Manley; S W Cowan-Jacob; E Buchdunger; D Fabbro; G Fendrich; P Furet; T Meyer; J Zimmermann
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162

10.  Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571).

Authors:  Bhushan Nagar; William G Bornmann; Patricia Pellicena; Thomas Schindler; Darren R Veach; W Todd Miller; Bayard Clarkson; John Kuriyan
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

View more
  16 in total

1.  The ABL kinase inhibitor imatinib causes phenotypic changes and lethality in adult Schistosoma japonicum.

Authors:  Xuesong Li; Simone Haeberlein; Lu Zhao; Mudassar N Mughal; Tao Zhu; Lu Liu; Rui Fang; Yanqin Zhou; Junlong Zhao; Christoph G Grevelding; Min Hu
Journal:  Parasitol Res       Date:  2019-02-07       Impact factor: 2.289

2.  SmSak, the second Polo-like kinase of the helminth parasite Schistosoma mansoni: conserved and unexpected roles in meiosis.

Authors:  Thavy Long; Mathieu Vanderstraete; Katia Cailliau; Marion Morel; Arlette Lescuyer; Nadege Gouignard; Christoph G Grevelding; Edith Browaeys; Colette Dissous
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

3.  Gonad RNA-specific qRT-PCR analyses identify genes with potential functions in schistosome reproduction such as SmFz1 and SmFGFRs.

Authors:  Steffen Hahnel; Thomas Quack; Sophia J Parker-Manuel; Zhigang Lu; Mathieu Vanderstraete; Marion Morel; Colette Dissous; Katia Cailliau; Christoph G Grevelding
Journal:  Front Genet       Date:  2014-06-10       Impact factor: 4.599

4.  Imatinib treatment causes substantial transcriptional changes in adult Schistosoma mansoni in vitro exhibiting pleiotropic effects.

Authors:  Christin Buro; Svenja Beckmann; Katia C Oliveira; Colette Dissous; Katia Cailliau; Richard J Marhöfer; Paul M Selzer; Sergio Verjovski-Almeida; Christoph G Grevelding
Journal:  PLoS Negl Trop Dis       Date:  2014-06-12

5.  Serum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib.

Authors:  Svenja Beckmann; Thavy Long; Christina Scheld; Rudolf Geyer; Conor R Caffrey; Christoph G Grevelding
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-08-07       Impact factor: 4.077

6.  Transcriptome analyses of inhibitor-treated schistosome females provide evidence for cooperating Src-kinase and TGFβ receptor pathways controlling mitosis and eggshell formation.

Authors:  Christin Buro; Katia C Oliveira; Zhigang Lu; Silke Leutner; Svenja Beckmann; Colette Dissous; Katia Cailliau; Sergio Verjovski-Almeida; Christoph G Grevelding
Journal:  PLoS Pathog       Date:  2013-06-13       Impact factor: 6.823

7.  Discovery of platyhelminth-specific α/β-integrin families and evidence for their role in reproduction in Schistosoma mansoni.

Authors:  Svenja Beckmann; Thomas Quack; Colette Dissous; Katia Cailliau; Gabriele Lang; Christoph G Grevelding
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

8.  Dual targeting of insulin and venus kinase Receptors of Schistosoma mansoni for novel anti-schistosome therapy.

Authors:  Mathieu Vanderstraete; Nadège Gouignard; Katia Cailliau; Marion Morel; Julien Lancelot; Jean-François Bodart; Colette Dissous
Journal:  PLoS Negl Trop Dis       Date:  2013-05-16

9.  Imatinib activity on Schistosoma mansoni.

Authors:  Naftale Katz; Flávia Fernanda Bubulo Couto; Neusa Araújo
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-11       Impact factor: 2.743

10.  Venus kinase receptors control reproduction in the platyhelminth parasite Schistosoma mansoni.

Authors:  Mathieu Vanderstraete; Nadège Gouignard; Katia Cailliau; Marion Morel; Steffen Hahnel; Silke Leutner; Svenja Beckmann; Christoph G Grevelding; Colette Dissous
Journal:  PLoS Pathog       Date:  2014-05-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.